Name: State of the Art Management of Type 1 Diabetes in Adults
Start: 24/03/2023 01:00 PM +00:00
End: 24/03/2023 09:00 PM +00:00

The Charles H. Best Diabetes Centre, fondly known as the Best Centre, is a one-of-a-kind community-based healthcare centre celebrating their 35th year! They are a registered charity that specializes in serving people of all ages, living with type 1 diabetes (T1D). Patient referrals come from all sources including: hospitals, primary care offices, community care centres and other specialists. The Best Centre care model is truly interdisciplinary and highly responsive to the individual needs of our patients and their caregivers. The clinical team follows T1D patients through all transitions in their medical care. The clinical and administrative teams work collaboratively to deliver many comprehensive programs including new diagnosis intensive education &amp; care, pediatric, youth, adult and senior programs. Also, we offer many pump programs for initial and upgrade training, an after-hours urgent care program and an integrated mental health counselling program. Our clinical team of educators is comprised of nurses, dietitians and social workers who partner with our affiliated physicians. Please visit www.charleshbest.com to learn more and follow us on social media. 
We are pleased to offer 3 patient care manuals for purchase. You will find this material to be perfect for your own learning and to share with your patients.&nbsp;
Please visit &nbsp;<a href="https://www.charleshbest.com/manuals">https://www.charleshbest.com/manuals</a> for purchase and download.&nbsp;
FACEBOOK: &nbsp;<a href="https://www.facebook.com/charleshbestdiabetes" target="_blank" rel="noopener">https://www.facebook.com/charleshbestdiabetes</a>
INSTAGRAM: &nbsp;<a href="https://www.instagram.com/charleshbest/?hl=en" target="_blank" rel="noopener">https://www.instagram.com/charleshbest/?hl=en</a>
We are pleased to offer 3 patient care manuals for purchase. You will find this material to be perfect for your own learning and to share with your patients.&nbsp; Please visit &nbsp;<a href="https://www.charleshbest.com/manuals" target="_blank" rel="noopener">https://www.charleshbest.com/manuals</a> for purchase and download.&nbsp;&nbsp;
For more information about The Charles H. Diabetes Centre, please connect with us:
General info: <a href="bestdiabetes@charleshbest.com">bestdiabetes@charleshbest.com</a>
Executive Director: <a href="lorrie@charleshbest.com">lorrie@charleshbest.com</a>
Development Officer (Campaign and Fundraising): <a href="amy@charleshbest.com">amy@charleshbest.com</a>
BUILDING ON THE BEST!
Today, there are 2,000 patients living with type 1 diabetes (T1D) who rely on the Best Centre to receive the care they need and deserve. &nbsp;Eighty-five percent of the Best Centre&rsquo;s patients come from every corner of Durham Region. &nbsp;We know Durham Region expects an astounding growth in population over the next two decades. &nbsp;As such, we must plan for the infrastructure needed, which includes healthcare services and our contribution within the larger healthcare system.&nbsp;
The demand for our patient services has increased at an annual average of 15% over the last decade. In fact, the Best Centre will need to double in size with an estimated future demand indicating a growth of 93% over the next ten years.
In response to the growth, forecasted demand and the need for more T1D expertise, The Charles H. Best Diabetes Centre launched the Building on the Best campaign, a capital expansion fundraising campaign to raise $8 million to meet the needs of a growing T1D community. The Best Centre has outgrown its capacity, requiring professional clinical staff to share offices and treatment spaces. WE have made great progress and are proud to be at 50% of our goal, please consider helping us to make this dream a reality.
<a href="https://www.buildingonthebest.ca">www.buildingonthebest.ca</a>
&nbsp;

The Charles H. Best Diabetes Centre

Engineering the extraordinary: Groundbreaking healthcare technology solutions for the most complex and challenging conditions. Inspiring hope and new possibility in people all over the world.
The most powerful hopes can be simple, ordinary. The father of a Type 1 diabetic who worries constantly about his son&rsquo;s blood sugar spiking when he&rsquo;s at a friend&rsquo;s house. A woman whose irregular heartbeat may be a sign of concern, not joy. Far too many people struggle profoundly to do things we should all be able to take for granted. Our resolve to improve every single life fuels our desire to make an extraordinary impact as the leader in healthcare technology.
&nbsp;We reimagine the treatment of over 70 of the world&rsquo;s most complex and challenging conditions. Not for the one, but for the many. Not someday, but this day. &nbsp;By bringing together data, artificial intelligence, and our deep knowledge of the human body, we create something even more extraordinary. In strengthening, lengthening, and saving lives, we restore hope and possibility.&nbsp;

Medtronic

Insulet Corporation is an innovative medical device company dedicated to simplifying life for people with diabetes through its Omnipod&reg; product platform. The Omnipod DASH&reg; Insulin Management System is a new, simple and discreet way to deliver insulin to your patients. More convenient than daily insulin injections and more comfortable than traditional tubed pumps, the Omnipod DASH&reg; System enables your patients to Simplify Life&reg; with diabetes.
The System consists of 2 parts:
The Pod - a tubeless, waterproof* insulin pump worn on-body, that holds up to 200 units of insulin and delivers continuous insulin therapy through customizable basal rates and bolus amounts.
The Personal Diabetes Manager (PDM) - a handheld, touchscreen device used to wirelessly control the Pod.&nbsp;
* The Pod has an IP28 rating rating for up to 7.6 m or 25 feet for 60 minutes. The PDM is not waterproof.

Insulet

WE&rsquo;RE HELPING PEOPLE WITH DIABETES LEAD HEALTHIER, HAPPIER LIVES.&nbsp;
As a global leader in diabetes care, Abbott is constantly working to deliver the highest quality products and unwavering support to our customers. Consistent and accurate glucose monitoring is the foundation of any diabetes management plan so we&rsquo;re committed to continuous improvement in the way patients and professionals measure, track and analyze glucose levels.&nbsp;
&copy; 2023 Abbott. FreeStyle, Libre, and related brand marks are marks of Abbott. Product images are for illustrative purposes only.
ADC-71662

Abbott

Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by Colonel Eli Lilly, who was committed to creating high quality medicines that meet people&rsquo;s needs, and today we remain true to that mission in all our work. Lilly employees work to discover and bring life-changing medicines to people who need them, improve the understanding and management of disease, and contribute to our communities through philanthropy and volunteerism. &nbsp;
Eli Lilly Canada was established in 1938, the result of a research collaboration with scientists at the University of Toronto which eventually produced the world&rsquo;s first commercially available insulin. Our work focuses on oncology, diabetes, autoimmunity, neurodegeneration, and pain. To learn more about Lilly Canada, please visit us at www.lilly.ca. &nbsp;
For our perspective on issues in healthcare and innovation, follow us on twitter @LillyPadCA. &nbsp;

Lilly

Tandem Diabetes Care, Inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience.&nbsp;
Tandem takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandem manufactures and sells the t:slim X2 insulin pump with Control-IQ technology. The t:slim X2 pump is capable of remote feature updates using a personal computer.&nbsp;
Tandem is based in San Diego, California.

Tandem

embecta, formerly part of BD (Becton, Dickinson and Company), is one of the largest pure-play diabetes care companies in the world, leveraging its nearly 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of more than 2,000 employees around the globe. For more information, visit embecta.com.

embecta

Novo Nordisk is a leading global healthcare company. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease.

Novo Nordisk

Dexcom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Founded in 1999, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom strives to simplify and improve diabetes management around the world. The Dexcom G6 real-time Continuous Glucose Monitoring (rtCGM) System sends real-time glucose readings continuously to a compatible smart device&dagger; or Dexcom receiver (optional). This system is approved for patients ages 2 years and older, wearable for 10-days and requires no routine fingersticks* or scanning. With real-time alerts, including a predictive Urgent Low Soon alert, the Dexcom G6 can warn the user in advance of hypoglycemia &mdash; allowing time to take appropriate action before it happens &mdash; day or night. When using the Dexcom Follow App, &Dagger; parents can also access their child's glucose levels remotely and be alerted if they are going out of target glucose range. The Dexcom G6 rtCGM System is now covered by most private insurers for people living with diabetes on rapidacting insulin as well as many provincial health programs.&sect; * If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood&nbsp; glucose meter to make diabetes treatment decisions. &dagger; For a list of compatible devices visit dexcom.com/compatibility. &Dagger; Internet connectivity required for data sharing. Following requires the use of the Follow App. Followers&nbsp; should always confirm readings on the Dexcom G6 App or Receiver before making treatment decisions. &sect; Conditions apply. For more information visit dexcom.com. Dexcom, Dexcom G6, Dexcom Share and Dexcom Follow are registered trademarks of Dexcom, Co. in the U.S., and may be registered in other countries. &copy; 2023 Dexcom Canada, Co. All rights reserved. LBL-10003457 Rev001

Dexcom

We are Sanofi, a global biopharmaceutical company committed to healthcare solutions from prevention to treatment. We turn scientific discoveries into medicine to improve health. Every day, we dedicate our most important resource, our people, to support patients and families through their health journey.
At Sanofi Canada, more than 2,000 people are dedicated to making a difference in patients' daily lives, wherever they live, and enabling them to enjoy a healthier life. It&rsquo;s a mission we&rsquo;ve been pursuing for more than 100 years.
In the early 1900s, we enabled the mass production of insulin, a revolutionary treatment that changed diabetes from a death sentence to a manageable disease. Over the following decades, we manufactured vaccines that controlled diphtheria, eliminated smallpox, and brought us just steps away from a polio-free world. Today, from four state-of-the-art facilities in Canada, we research, develop, manufacture and distribute Sanofi products to people in this country and around the world.

Sanofi

Ontario Tech University Continuous Learning is proud to offer the Type 1 Diabetes Certificate program for regulated healthcare professionals. &nbsp;The program consists of ten (10) modules designed to increase knowledge about type 1 diabetes, its treatment, care options and techniques specific to working with people living with type 1 diabetes. These modules provide a solid foundation of clinical and practical knowledge of type 1 diabetes; its presentation during various life stages and events (e.g. pregnancy), blood glucose management, various care/treatment technologies, insulin adjustment, the effects of nutrition and exercise, types of complications and suggested treatment, and a professional practice perspective.
This program is provided in partnership with Charles H. Best Diabetes Centre:
Since 1989, The Charles H. Best Diabetes Centre specializes in caring for people living with type 1 diabetes. Their mission is to keep children, youth and adults living with type 1 diabetes healthy until a cure is found.
The Charles H. Best Diabetes Centre is indebted to its founder, Marlene Grass for envisioning this work. Thank you to all of the Best Centre educators who contributed to the initial scoping of the certificate course outline. Specifically, we would like to recognize the people who provided significant contribution to the development of all of the modules. Special thanks to: Diana Balicsak, RD; Jeremy Gilbert, MD; Lorrie Hagen, MHSc, RD; Margaret Korosec, RN; Sandy Hubbard, RN; Kerry Katz, RN; Susan Kettle, RD.
The creation of this course is in response to the interest from the healthcare community at large, with the goal of spreading type 1 healthcare knowledge across the globe.

Ontario Tech University

Diabetes Depot is Canada&rsquo;s original online shop for diabetes and insulin pump supplies, savings and support!
We carry insulin pump supplies for Tandem, Medtronic and Ypsomed pumps; as well as CGM supplies from Dexcom, Libre and Medtronic.
Diabetes Depot is operated by LMC Pharmacy. &nbsp;As an affiliate of LMC Diabetes &amp; Endocrinology we are pleased to offer workshops, ask-the-expert sessions and lots of education and handouts of a variety of diabetes topics, from technology to troubleshooting tips! &nbsp;Webinar leaders, content providers and teammates include Certified Pump Trainers, Certified Diabetes Educator RN, RD and pharmacists, as well as fellow T1Ds!

Diabetes Depot

Type 1 Diabetes TrialNet is an international network of physicians, scientists and healthcare teams at the forefront of type 1 diabetes researchers.&nbsp;
Relatives of people with type 1 diabetes are 15 times more likely to develop the disease than the general population. We offer risk screening for relatives of people with type 1 diabetes to evaluate their personal risk of developing the disease. This unique screening can identify the early stages of type 1 diabetes years before any symptoms appear. Here at TrialNet, we offer an in-home test kit requiring a finger-stick blood sample or a venipuncture kit that you can take to a local lab. We also visit local hospitals throughout the year and have screening events.
If your screening results show you are in early stages of type 1 diabetes, you may be eligible for a TrialNet prevention study. Through innovative clinical studies testing ways to slow down and prevent disease progression, we are one step closer to our goal: a future without T1D!

TrialNet

Lorrie Hagen, RD, MHSc, CHE
Executive Director
The Charles H. Best Diabetes Centre

Opening Remarks

Advances in Technology: State of the Art Update on Closed Loop Insulin Pump Delivery

The Importance of Making a Diagnosis: Monogenic Diabetes and Personalized Medicine

Dr. Louis Liu, MD, PhD, FRCPC, CAGF Dr. Lisa Dubrofski, MD, FRCPC, MAS
Moderator: Dr. Jacqueline James, MD,MEd, FRCPC

AGENDA

The Charles H. Best Diabetes Centre1 The Charles H. Best Diabetes Centre

The Charles H. Best Diabetes Centre

SPONSORS12 SPONSORS

Medtronic

Insulet

Abbott

Lilly

Tandem

embecta

Novo Nordisk

Dexcom

Sanofi

Ontario Tech University

Diabetes Depot

TrialNet

AGENDA

The Charles H. Best Diabetes Centre.css-7303n9{margin:0;font-size:1.4rem;font-weight:500;line-height:1.5;color:#5d5d5d;font-family:'Poppins',sans-serif;color:#FFFFFF;margin-left:0.8rem;font-weight:400;}1 The Charles H. Best Diabetes Centre

The Charles H. Best Diabetes Centre

SPONSORS12 SPONSORS

Medtronic

Insulet

Abbott

Lilly

Tandem

embecta

Novo Nordisk

Dexcom

Sanofi

Ontario Tech University

Diabetes Depot

TrialNet

The Charles H. Best Diabetes Centre1 The Charles H. Best Diabetes Centre